Literature DB >> 18849328

Adenosine A2A and beta-adrenergic calcium transient and contractile responses in rat ventricular myocytes.

James G Dobson1, Lynne G Shea, Richard A Fenton.   

Abstract

The adenosine A2A receptor (A2AR) enhances cardiac contractility, and the adenosine A1R receptor (A1R) is antiadrenergic by reducing the adrenergic beta1 receptor (beta1R)-elicited increase in contractility. In this study we compared the A2AR-, A1R-, and beta1R-elicited actions on isolated rat ventricular myocytes in terms of Ca transient and contractile responses involving PKA and PKC. Stimulation of A2AR with 2 microM (approximately EC50) CGS-21680 (CGS) produced a 17-28% increase in the Ca transient ratio (CTR) and maximum velocities (Vmax) of transient ratio increase (+MVT) and recovery (-MVT) but no change in the time-to-50% recovery (TTR). CGS increased myocyte sarcomere shortening (MSS) and the maximum velocities of shortening (+MVS) and relaxation (-MVS) by 31-34% with no change in time-to-50% relengthening (TTL). beta1R stimulation using 2 nM (approximately EC50) isoproterenol (Iso) increased CTR, +MVT, and -MVT by 67-162% and decreased TTR by 43%. Iso increased MSS, +MVS, and -MVS by 153-174% and decreased TTL by 31%. The A2AR and beta1R Ca transient and contractile responses were not additive. The PKA inhibitor Rp-adenosine 3',5'-cyclic monophosphorothioate triethylamonium salt prevented both the CGS- and Iso-elicited contractile responses. The PKC inhibitors chelerythrine and KIE1-1 peptide (PKCepsilon specific) prevented the antiadrenergic action of A1R but did not influence A2AR-mediated increases in contractile variables. The findings suggest that cardiac A2AR utilize cAMP/PKA like beta1R, but the Ca transient and contractile responses are less in magnitude and not equally affected. Although PKC is important in the A1R antiadrenergic action, it does not seem to play a role in A2AR-elicited Ca transient and contractile events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849328      PMCID: PMC2614550          DOI: 10.1152/ajpheart.00927.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Adenosine A2 receptor function in rat ventricular myocytes.

Authors:  J G Dobson; R A Fenton
Journal:  Cardiovasc Res       Date:  1997-05       Impact factor: 10.787

2.  A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.

Authors:  J A Johnson; M O Gray; C H Chen; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

3.  The contractile response of the ventricular myocardium to adenosine A1 and A2 receptor stimulation.

Authors:  J G Dobson; R A Fenton; D R Sawmiller
Journal:  Ann N Y Acad Sci       Date:  1996-09-30       Impact factor: 5.691

Review 4.  Multiple pathway signal transduction by the cAMP-dependent protein kinase.

Authors:  D A Walsh; S M Van Patten
Journal:  FASEB J       Date:  1994-12       Impact factor: 5.191

5.  A new cyclic AMP-independent, Gs-mediated stimulatory mechanism via the adenosine A2a receptor in the intact cardiac cell.

Authors:  B T Liang; J F Morley
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

Review 6.  Signal transduction in ischemic preconditioning.

Authors:  J M Downey; M V Cohen
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

7.  Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.

Authors:  B T Liang; B Haltiwanger
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

8.  Fluorometric quantitation of adenosine concentration in small samples of extracellular fluid.

Authors:  R A Fenton; J G Dobson
Journal:  Anal Biochem       Date:  1992-11-15       Impact factor: 3.365

9.  Endogenous adenosine is an antiarrhythmic agent.

Authors:  J B Conti; L Belardinelli; D B Utterback; A B Curtis
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

10.  8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.

Authors:  K A Jacobson; O Nikodijević; W L Padgett; C Gallo-Rodriguez; M Maillard; J W Daly
Journal:  FEBS Lett       Date:  1993-05-24       Impact factor: 4.124

View more
  10 in total

1.  Reduced adenosine release from the aged mammalian heart.

Authors:  Richard A Fenton; James G Dobson
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

2.  Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

Authors:  P Charukeshi Chandrasekera; Victoria J McIntosh; Frank X Cao; Robert D Lasley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

3.  Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27.

Authors:  Richard A Fenton; Lynne G Shea; Cecilia Doddi; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

4.  Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes.

Authors:  Satoshi Komatsu; James G Dobson; Mitsuo Ikebe; Lynne G Shea; Richard A Fenton
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

5.  Involvement of β-adrenoceptors in the cardiovascular responses induced by selective adenosine A2A and A2B receptor agonists.

Authors:  Edward S Wragg; Patrizia Pannucci; Stephen J Hill; Jeanette Woolard; Samantha L Cooper
Journal:  Pharmacol Res Perspect       Date:  2022-06

6.  Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.

Authors:  Sergio Signore; Andrea Sorrentino; João Ferreira-Martins; Ramaswamy Kannappan; Mehrdad Shafaie; Fabio Del Ben; Kazuya Isobe; Christian Arranto; Ewa Wybieralska; Andrew Webster; Fumihiro Sanada; Barbara Ogórek; Hanqiao Zheng; Xiaoxia Liu; Federica Del Monte; David A D'Alessandro; Oriyanhan Wunimenghe; Robert E Michler; Toru Hosoda; Polina Goichberg; Annarosa Leri; Jan Kajstura; Piero Anversa; Marcello Rota
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

7.  Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.

Authors:  Richard A Fenton; Satoshi Komatsu; Mitsuo Ikebe; Lynne G Shea; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

8.  Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension.

Authors:  Ming-Fen Ho; Leanne M Low; Roselyn B Rose'Meyer
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

9.  Oligomeric structure and functional characterization of the urea transporter from Actinobacillus pleuropneumoniae.

Authors:  Stefan Raunser; John C Mathai; Priyanka D Abeyrathne; Amanda J Rice; Mark L Zeidel; Thomas Walz
Journal:  J Mol Biol       Date:  2009-02-11       Impact factor: 5.469

Review 10.  Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Cells       Date:  2020-03-24       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.